supp.fit

Docosahexaenoic Acid, Fish Oil and Eicosapentaenoic Acid: study protocols

19 study groups took Docosahexaenoic Acid together with Fish Oil and Eicosapentaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Docosahexaenoic Acid: what the research found →

Dose per serving from research: Docosahexaenoic Acid

19 study groups in 17 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g and 1 g to 2.5 g, 32% of 19 study groups each.

Daily doseStudy groups
100 mg to 250 mg
2
250 mg to 500 mg
4
500 mg to 1 g
6
1 g to 2.5 g
6
over 2.5 g
1

Dose per serving from research: Fish Oil

10 study groups in 9 studies say how much Fish Oil participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 g to 10 g, 50% of 10 study groups.

Daily doseStudy groups
1 g or less
1
1 g to 2.5 g
2
2.5 g to 5 g
2
5 g to 10 g
5

Dose per serving from research: Eicosapentaenoic Acid

18 study groups in 16 studies say how much Eicosapentaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 33% of 18 study groups.

Daily doseStudy groups
50 mg to 100 mg
3
100 mg to 250 mg
5
250 mg to 500 mg
1
500 mg to 1 g
0
1 g to 2.5 g
6
2.5 g to 5 g
3

Commonly used together

4 of 19 study groups took Docosahexaenoic Acid, Fish Oil and Eicosapentaenoic Acid with something else, but nothing that 3 or more different studies gave.

19 study groups

Study
Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
2009 · fish-oil intervention group · Adults with metabolic syndrome; mean age 52.9 years; sex not specified
120 mg1 g180 mg26 weeks60
Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial
2012 · n-3 LCPUFA group · Pregnant women from Adelaide whose unborn baby had a mother, father, or sibling with a history of medically diagnosed allergic disease
800 mg1.5 g100 mg—368
Prenatal Fish Oil Supplementation and Allergy: 6-Year Follow-up of a Randomized Controlled Trial
2016 · n-3 LCPUFA-rich fish oil capsules · Pregnant women with a family history of allergic disease
800 mg—100 mg—367
The effect of perinatal fish oil supplementation on neurodevelopment and growth of infants: a randomized controlled trial
2018 · fish oil supplementation group · Pregnant women aged 18–35 years
120 mg—180 mg—75
Fish oil supplementation reduces cortisol basal levels and perceived stress: a randomized, placebo-controlled trial in abstinent alcoholics
2013 · fish-oil supplementation · Adult men with alcohol dependence undergoing residential rehabilitation
252 mg—60 mg3 weeks—
Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: Secondary analysis of data from a randomized controlled trial
2024 · n-3 PUFAs supplementation · Outpatients with first-diagnosed, drug-naïve depression receiving venlafaxine; age and sex not reported
960 mg2.4 g1.44 g12 weeks—
Effects of dietary supplementation with a combination of fish oil, bilberry extract, and lutein on subjective symptoms of asthenopia in humans
2011 · Active group · People with subjective symptoms of asthenopia; age and sex not reported
783 mg—162 mg4 weeks11
Fish oil amplifies the effect of propranolol in mild essential hypertension
1990 · Third subgroup: propranolol plus fish oil · Men with mild essential hypertension
1.1 g9 g1.8 g12 weeks16
The effects of supplemental fish oil on blood pressure and morning cortisol in normotensive adults: a pilot study
2012 · Fish Oil (FO) · Adults, mean age 35±13 years, normotensive
800 mg4 g1.6 g6 weeks—
Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach
2020 · n-3 PUFA supplementation · Adults; age, sex, and health condition not specified
1.1 g5 g—6 weeks210
Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients
2014 · omega-3 group · Adults undergoing maintenance hemodialysis
720 mg—1.08 g120 days25
Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer
1992 · fish oil group · Patients with sporadic adenomatous colorectal polyps; age and sex not reported
3.6 g—4.1 g12 weeks10
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects
1994 · fish oil · Subjects without cystic fibrosis; mean age 13.4 years
2.2 g8 g3.2 g6 weeks8
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects
1994 · fish oil · Patients with cystic fibrosis and pancreatic insufficiency; mean age 12.2 years
2.2 g8 g3.2 g6 weeks7
Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women
2008 · fish oil (FO) · pregnant women; age and health condition not specified
500 mg—150 mg——
[Effect on the lipid profile of diet supplemented with fish oil concentrate]
1990 · n-3 treated group · male and female patients with cholesterol values higher than 7.0 mmol/l
1.5 g6 g2.1 g12 weeks—
The immunomodulatory effects of fish-oil supplementation in elite paddlers: A pilot randomized double blind placebo-controlled trial
2015 · fish-oil capsules · male elite paddlers undertaking an increasing exercise program
1.2 g6 g2.4 g4 weeks11
Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye
2011 · omega-3 group · Patients with dry eye; age and sex not reported
300 mg—450 mg90 days—
Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women
2008 · fish oil (FO) and methyl-tetra-hydrofolic acid · pregnant women; age and health condition not specified
500 mg—150 mg——